These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 31670495)
21. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma. Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530 [TBL] [Abstract][Full Text] [Related]
22. CENPE, PRC1, TTK, and PLK4 May Play Crucial Roles in the Osteosarcoma Progression. Wang F; Zhao Q; Liu W; Kong D Technol Cancer Res Treat; 2020; 19():1533033820973278. PubMed ID: 33176597 [TBL] [Abstract][Full Text] [Related]
23. Identification of Key Genes and miRNAs Affecting Osteosarcoma Based on Bioinformatics. Li L; Zhou X; Zhang W; Zhao R Dis Markers; 2022; 2022():1015593. PubMed ID: 36438897 [TBL] [Abstract][Full Text] [Related]
24. Anoctamin 5 promotes osteosarcoma development by increasing degradation of Nel-like proteins 1 and 2. Pan R; Lu Q; Ren C; Li H; Zeng F; Tian X; Chen H Aging (Albany NY); 2021 Jul; 13(13):17316-17327. PubMed ID: 34238763 [TBL] [Abstract][Full Text] [Related]
25. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways. Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116 [TBL] [Abstract][Full Text] [Related]
26. [Advances in the pathologic study on chromosome genes in osteosarcoma]. Zhao B; Yang GH Zhonghua Bing Li Xue Za Zhi; 1994 Feb; 23(1):54-5. PubMed ID: 8044864 [No Abstract] [Full Text] [Related]
27. Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes. Liu W; Xie X; Qi Y; Wu J JAMA Netw Open; 2021 Aug; 4(8):e2119132. PubMed ID: 34342651 [TBL] [Abstract][Full Text] [Related]
28. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts. Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057 [TBL] [Abstract][Full Text] [Related]
29. Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy. Gianferante DM; Mirabello L; Savage SA Nat Rev Endocrinol; 2017 Aug; 13(8):480-491. PubMed ID: 28338660 [TBL] [Abstract][Full Text] [Related]
30. The role of significantly deregulated MicroRNAs in osteosarcoma based on bioinformatic analysis. Liu J; Wu S; Xie X; Wang Z; Lei Q Technol Health Care; 2021; 29(2):333-341. PubMed ID: 32568133 [TBL] [Abstract][Full Text] [Related]
31. A Sleeping Beauty Screen Highlights Cancer Drivers in Osteosarcoma. Cancer Discov; 2015 Jul; 5(7):690. PubMed ID: 25998401 [TBL] [Abstract][Full Text] [Related]
32. Polymorphisms of genes related to metotrexate response and toxicity in high-grade osteosarcoma. Serra M; Hattinger CM Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):123. PubMed ID: 27852114 [No Abstract] [Full Text] [Related]
33. High Expression of N-Acetylgalactosaminyl-transferase 1 (GALNT1) Associated with Invasion, Metastasis, and Proliferation in Osteosarcoma. Zhang L; Lv B; Shi X; Gao G Med Sci Monit; 2020 Dec; 26():e927837. PubMed ID: 33284788 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values. Li M; Cheng WT; Li H; Zhang Z; Lu XL; Deng SS; Li J; Yang CH Curr Med Sci; 2021 Oct; 41(5):916-929. PubMed ID: 34671904 [TBL] [Abstract][Full Text] [Related]
35. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma. Chen J; Guo X; Zeng G; Liu J; Zhao B Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842 [TBL] [Abstract][Full Text] [Related]
36. Current concepts on the molecular biology of osteosarcoma. Gorlick R Cancer Treat Res; 2009; 152():467-78. PubMed ID: 20213409 [TBL] [Abstract][Full Text] [Related]
37. Pleckstrin homology-like domain family A, member 3, a miR-19a-3p-regulated gene, suppresses tumor growth in osteosarcoma by downregulating the Akt pathway. Wang P; Huang Y; Xia X; Han J; Zhang L; Zhao W Bioengineered; 2022 Feb; 13(2):3993-4009. PubMed ID: 35112982 [TBL] [Abstract][Full Text] [Related]
38. Genome-wide analyses of XRN1-sensitive targets in osteosarcoma cells identify disease-relevant transcripts containing G-rich motifs. Pashler AL; Towler BP; Jones CI; Haime HJ; Burgess T; Newbury SF RNA; 2021 Oct; 27(10):1265-1280. PubMed ID: 34266995 [TBL] [Abstract][Full Text] [Related]
39. Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor. Kuijjer ML; Hogendoorn PC; Cleton-Jansen AM Int J Cancer; 2013 Dec; 133(11):2512-21. PubMed ID: 23436697 [TBL] [Abstract][Full Text] [Related]
40. Questions about XY Wen et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis". Liu F; Zhang Q Tumour Biol; 2015 Feb; 36(2):557-8. PubMed ID: 25663465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]